Related Experiment Video
Updated: Aug 12, 2026

12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Small cells in hepatoblastoma lack "oval" cell phenotype
1Department of Pathology, Indiana University, Indianapolis, Indiana, USA. sbadve@iupui.edu
Summary
Hepatoblastoma's undifferentiated cells lack markers of hepatic stem cells, challenging their origin. This suggests potential differences in liver progenitor cells and tumor antigen expression.
Area of Science:
- Pediatric Oncology
- Hepatology
- Cell Biology
Background:
- Hepatoblastoma is a childhood liver tumor with epithelial and mesenchymal components.
- The undifferentiated blastemal cells are hypothesized to be neoplastic hepatocyte progenitor cells.
Purpose of the Study:
- To investigate the immunophenotype of hepatoblastoma epithelial cells, particularly the undifferentiated component.
- To compare these cells with adult hepatocytes and hepatic stem (oval) cells.
Main Methods:
- Immunohistochemical staining of 10 hepatoblastoma tissues using antibodies against CD34, alpha1 microglobulin, Bcl-2, HepPar-1, and CK19.
- Comparison of marker expression in undifferentiated cells versus differentiated hepatocyte-like cells.
Main Results:
- Undifferentiated hepatoblastoma cells did not express markers (Bcl-2, HepPar-1, alpha1 microglobulin, CD34, CK19) characteristic of hepatic stem cells.
- Differentiated hepatocyte-like cells showed positivity for alpha1 microglobulin and HepPar-1, correlating with differentiation.
- Bcl-2 and CK19 expression were observed in areas of ductular differentiation.
Conclusions:
- The immunophenotype of hepatoblastoma's undifferentiated cells differs from hepatic stem cells, questioning the tumor's origin and nomenclature.
- Findings suggest potential dysregulation of tumor antigen expression in hepatoblastoma.
- The study raises questions about the existence of distinct liver progenitor cell populations (oval vs. blastemal cells) with different immunophenotypes.

